A Study of Tirzepatide (LY3298176) Compared With Semaglutide in Participants With Type 2 Diabetes

Phase 3 · May 17, 2019

A Research Study to Look at How Semaglutide Works Compared to Placebo in People With Overweight or Obesity

Phase 3 · Jun 1, 2018

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 133 in Adult Subjects With Overweight/Obesity

Phase 1 · Mar 1, 2018

A Study to Evaluate the Effect of CagriSema on Body Weight in Adults Living With Overweight or Obesity

Phase 3 · Jul 13, 2023

A Study of Tirzepatide for the Treatment of Obesity or Overweight in Participants Without Type 2 Diabetes

Phase 3 · Dec 2, 2019

A Study of Retatrutide in Participants With Obesity or Overweight

Phase 3 · Sep 8, 2022

A Study of Danuglipron in Participants With Type 2 Diabetes

Phase 2 · Sep 20, 2022

A Study of Lotiglipron in Participants With Type 2 Diabetes

Phase 2 · Aug 15, 2022

A Study of CT-388 in Participants With Obesity or Overweight

Phase 1 · Jan 15, 2024

A Study to Evaluate Survodutide in Participants With Non-alcoholic Steatohepatitis (NASH)

Phase 2 · Nov 3, 2022

A Study of GSBR-1290 in Healthy Participants and Participants With Type 2 Diabetes

Phase 1 · Mar 10, 2022

A Study of Orforglipron in Participants With Obesity or Overweight

Phase 3 · May 15, 2023